KPF
USNA icon

K2 Principal Fund’s Usana Health Sciences USNA Stock Holding History

K2 Principal Fund’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$359K – 379
2024
Q4 		$359K Buy
+10,000
New +$374K 0.04% 208

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

K2 Principal Fund's USNA Position: Q1 2025 in Review

K2 Principal Fund sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 10,000 shares — an estimated $359K sold.

K2 Principal Fund first reported a position in USNA in Q4 2024 and held it in 1 quarter. The position peaked at $359K in Q4 2024. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • K2 Principal Fund reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • K2 Principal Fund sold 10,000 Usana Health Sciences shares in Q1 2025, an estimated $359K.
  • K2 Principal Fund first reported a position in Usana Health Sciences in Q4 2024 and held it in 1 quarter.
  • K2 Principal Fund's Usana Health Sciences position peaked at $359K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on K2 Principal Fund's 13F filing for Q1 2025, filed 15 May 2025.